Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TTR | P02766 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31196527 | 1.00 | SUCNR1 (0.43) | SUCNR1HSD17B10TTRTSHRKDM4E | |
| SCHEMBL350769 | 1.00 | SUCNR1 (0.43) | SUCNR1HSD17B10TTRTSHRKDM4E | |
| SCHEMBL9514859 | 1.00 | SUCNR1 (0.43) | SUCNR1HSD17B10TTRTSHRKDM4E | |
| SCHEMBL28611363 | 0.91 | SUCNR1 (0.50) | SUCNR1TSHRKDM4EALDH1A1 | |
| SCHEMBL9514945 | 0.83 | THRB (0.39) | SUCNR1TSHR | |
| SCHEMBL6793013 | 0.82 | SUCNR1 (0.30) | SUCNR1 | |
| SCHEMBL11298204 | 0.78 | SUCNR1 (0.43) | SUCNR1KDM4EALDH1A1 | |
| SCHEMBL6789695 | 0.76 | KDM4E (0.37) | TTRKDM4ESMN1; SMN2 | |
| SCHEMBL7683264 | 0.74 | SUCNR1 (0.39) | SUCNR1KDM4EALDH1A1 | |
| SCHEMBL731703 | 0.73 | SUCNR1 (0.50) | SUCNR1TSHRKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117320758-A | Composition for tissue separation comprising a fluid gel | 阿莱奥BME公司 | 2023-12-29 | — | — | CN | claimed |
| EP-0341409-B1 | Platinum (II) complexes, their preparation and use as antitumour agents | BOEHRINGER MANNHEIM ITALIA (IT) | 1993-12-29 | — | — | EP | claimed |
| EP-4392476-A1 | TOUGHENED BRANCHED POLY(HYDROXYACID) COMPOSITION | Solvay Specialty Polymers USA, LLC (US) | 2024-07-03 | — | — | EP | disclosed |
| CN-118251438-A | Toughened branched poly (hydroxy acid) compositions | 索尔维特殊聚合物美国有限责任公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-114829448-B | Glycolic acid polymers | 索尔维特殊聚合物美国有限责任公司 | 2024-04-19 | — | — | CN | disclosed |
| EP-4313171-A1 | COMPOSITIONS COMPRISING FLUID GELS FOR TISSUE SEPARATION | Aleo BME, Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| CN-117320758-A | Composition for tissue separation comprising a fluid gel | 阿莱奥BME公司 | 2023-12-29 | — | — | CN | disclosed |
| CN-113015768-B | Polymer composition | 索尔维公司 | 2023-11-17 | — | — | CN | disclosed |
| CN-115799614-A | Secondary battery | 珠海冠宇电池股份有限公司 | 2023-03-14 | — | — | CN | disclosed |
| WO-2023025718-A1 | TOUGHENED BRANCHED POLY(HYDROXYACID) COMPOSITION | SOLVAY SPECIALTY POLYMERS USA, LLC (US) | 2023-03-02 | — | — | WO | disclosed |
| EP-4081595-A1 | CURABLE PHOTOCHROMIC COMPOSITIONS INCLUDING AN OXAZOLINE FUNCTIONAL MATERIAL | Transitions Optical, Ltd. (IE) | 2022-11-02 | — | — | EP | disclosed |
| CN-114829740-A | Downhole tool components comprising branched poly (hydroxy acids) | 索尔维特殊聚合物美国有限责任公司 | 2022-07-29 | — | — | CN | disclosed |
| US-10240011-B2 | Multifunctional curing agents and their use in improving strength of composites containing carbon fibers embedded in polymeric matrix | UT-BATTELLE, LLC (US) | 2019-03-26 | — | — | US | disclosed |
| US-20170166712-A1 | MULTIFUNCTIONAL CURING AGENTS AND THEIR USE IN IMPROVING STRENGTH OF COMPOSITES CONTAINING CARBON FIBERS EMBEDDED IN POLYMERIC MATRIX | UT-BATTELLE, LLC (US) | 2017-06-15 | — | — | US | disclosed |
| US-9617398-B2 | Multifunctional curing agents and their use in improving strength of composites containing carbon fibers embedded in a polymeric matrix | UT-BATTELLE, LLC (US) | 2017-04-11 | — | — | US | disclosed |
| US-20160102180-A1 | MULTIFUNCTIONAL CURING AGENTS AND THEIR USE IN IMPROVING STRENGTH OF COMPOSITES CONTAINING CARBON FIBERS EMBEDDED IN A POLYMERIC MATRIX | UT-BATTELLE, LLC (US) | 2016-04-14 | — | — | US | disclosed |
| US-20150165380-A1 | DRAW SOLUTES COMPRISING ALKYL AMMONIUM SALT COMPOUNDS | LOTTE CHEMICAL CORPORATION (KR) | 2015-06-18 | — | — | US | disclosed |
| EP-0341409-B1 | Platinum (II) complexes, their preparation and use as antitumour agents | BOEHRINGER MANNHEIM ITALIA (IT) | 1993-12-29 | — | — | EP | disclosed |
| EP-0415939-A1 | PLATINUM(II) COMPLEXES, THEIR PREPARATION AND USE AS ANTI-TUMOUR AGENTS | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1991-03-13 | — | — | EP | disclosed |
| WO-1989009218-A1 | PLATINUM(II) COMPLEXES, THEIR PREPARATION AND USE AS ANTI-TUMOUR AGENTS | BOEHRINGER BIOCHEMIA ROBIN S.P.A. (IT) | 1989-10-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150165380-A1 | DRAW SOLUTES COMPRISING ALKYL AMMONIUM SALT COMPOUNDS | SLC34A3, SLC43A1, SLC34A1 | SUCNR1 1544/4885HSD17B10 3726/4885TTR 2752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.